Literature DB >> 6433318

Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.

L M Osborn, C Lenarsky, R C Oakes, M I Reiff.   

Abstract

Current guidelines for treatment of hemolytic disease of the newborn make no differentiation between ABO and Rh incompatibility. A protocol that prolonged the observation period in full-term, ABO-incompatible infants with positive Coombs' tests who were otherwise healthy was tested. Postponement of treatment made it possible to determine more accurately which infants needed phototherapy. This dramatically decreased the number of infants treated without increasing their risk of requiring exchange transfusion.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6433318

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


  8 in total

1.  Neonatal jaundice due to ABO incompatibility in Sri Lankan.

Authors:  G N Lucas
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Authors:  Michael Kaplan; Cathy Hammerman; Hendrik J Vreman; Ronald J Wong; David K Stevenson
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

3.  Sixth hour transcutaneous bilirubin predicting significant hyperbilirubinemia in ABO incompatible neonates.

Authors:  Ramesh Y Bhat; Pavan C G Kumar
Journal:  World J Pediatr       Date:  2013-06-17       Impact factor: 2.764

4.  Phototherapy: the hospital as risk factor.

Authors:  A Van Enk; R de Leeuw
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

Review 5.  Use of phototherapy for neonatal hyperbilirubinemia. Fetus and Newborn Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1986-06-01       Impact factor: 8.262

Review 6.  Neonatal jaundice--a lighter touch.

Authors:  K L Dodd
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

7.  Unusually severe ABO hemolytic disease of newborn.

Authors:  J Goraya; S Basu; P Sodhi; S Mehta
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

8.  Early diagnosis of ABO haemolytic disease of the newborn.

Authors:  R S Procianoy; C B Giacomini; D M Farina; G A Mollin; M I Winckler; M B Silveira; L Campos; J P Marques-Pereira
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.